New Market Study, "BioMedomics, Inc - Product Pipeline Analysis, 2014 Update", Has Been Published
BioMedomics, Inc. (BioMedomics) is a medical diagnostics company. The company conducts research and develops assays and technologies for use in molecular diagnostics. Its diagnostic platform technologies include time-resolved lateral flow immunoassay platform, nanotube based highly sensitive biosensor platform, and novel universal bacterial capture technology. BioMedomics offer tests for sickle cell disease, acetaminophen, H.I.T, and alpha-thalassemia. The company's rapid drug overdose test is used to test drugs of abuse including morphine, cocaine, PCP, methamphetamine and THC. It markets its assays and...
View full press release